Quan Vu
Chief Accounting Officer
Monopar Therapeutics (MNPR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-03–present
-
Monopar Therapeutics (MNPR)
SEC 8-K
Current2025-03-03–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Monopar Therapeutics (MNPR) | Chief Financial Officer, Secretary, and Treasurer | $305,000 | $2,101,314 |
| 2024 | Monopar Therapeutics (MNPR) | Chief Financial Officer, Secretary, and Treasurer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.